Tandem Diabetes Care, Inc. (TNDM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1161440,
    "name": "Tandem Diabetes Care, Inc.",
    "stock_name": "Tandem Diabetes Care, Inc.",
    "full_name": "Tandem Diabetes Care, Inc.",
    "name_url": "stocks-analysis/tandem-diabetes-care-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "20.71",
    "chg": 1.09,
    "chgp": "5.56%",
    "dir": 1,
    "prev_price": "19.62",
    "mcapval": "844.62",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US8753722037",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "911.59 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/tandem-diabetes-care-inc-1161440-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Tandem Diabetes Care Stock Soars 21.98%, Hits Intraday High of $16.70",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tandem-diabetes-care-stock-soars-2198-hits-intraday-high-of-1670-3686541",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TandemDiabetesC_priceRelatedfactors_3686541.png",
        "date": "2025-11-10 17:49:11",
        "description": "Tandem Diabetes Care, Inc. has seen notable stock activity today, contrasting with the modest performance of the S&P 500. While the company has gained significantly over the past week, its year-long performance reveals a substantial decline. The firm continues to face challenges with profitability and has a market capitalization of USD 845 million."
      },
      {
        "title": "Tandem Diabetes Care Hits Day Low at $13.25 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tandem-diabetes-care-hits-day-low-at-1325-amid-price-pressure-3680245",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TandemDiabetesC_priceRelatedfactors_3680245.png",
        "date": "2025-11-07 16:37:17",
        "description": "Tandem Diabetes Care, Inc. faced notable volatility on November 6, 2025, with a significant stock decline. Over the past week and month, the stock has continued to drop, reflecting a troubling long-term performance. Financial metrics reveal challenges, including low return on equity and high debt levels, indicating ongoing difficulties."
      },
      {
        "title": "Tandem Diabetes Care Experiences Revision in Stock Evaluation Amid Market Fluctuations",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tandem-diabetes-cares-technical-trend-shifts-from-bearish-to-mildly-bearish-amid-stock-price-increase-3601202",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/TandemDiabetesC_technicaldot_3601202.png",
        "date": "2025-10-07 20:23:09",
        "description": "Tandem Diabetes Care, Inc. has experienced significant stock fluctuations, with a 52-week high of $42.70 and a low of $9.98. Recent evaluations show mixed technical indicators, and the company's performance has lagged behind the S&P 500, reflecting ongoing challenges in the market."
      },
      {
        "title": "Is Tandem Diabetes Care, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-tandem-diabetes-care-inc-technically-bullish-or-bearish-3598978",
        "imagepath": "",
        "date": "2025-10-07 12:15:01",
        "description": "As of 3 October 2025, the technical trend for Tandem Diabetes Care, Inc. has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, but the monthly MACD remains bearish. The daily moving averages are mildly bearish, and both the weekly and monthly Bollinger Bands are also mildly bearish. The KST and Dow Theory show bearish and mildly bearish signals respectively on the weekly and monthly time frames. \n\nIn terms of performance, the stock has outperformed the S&P 500 over the past week and month, with returns of 27.31% and 19.32% compared to 1.09% and 4.15% for the index. However, the longer-term returns are significantly negative, with a year-to-date return of -58.33% and a one-year return of -64.07%, while the S&P 500 has gained 14.18% and 17.82% respectively. Overall, the current technical stance is mildly bearish...."
      },
      {
        "title": "Tandem Diabetes Care Stock Soars 12.2% to Intraday High of $14.85",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tandem-diabetes-care-stock-soars-122-to-intraday-high-of-1485-3595711",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/TandemDiabetesC_priceRelatedfactors_3595711.png",
        "date": "2025-10-06 18:07:37",
        "description": "Tandem Diabetes Care, Inc. saw a notable increase in its stock price on October 3, 2025, reflecting strong short-term performance compared to the S&P 500. However, the company faces long-term challenges, including significant declines over the past year and five years, alongside concerns regarding its financial health."
      },
      {
        "title": "Is Tandem Diabetes Care, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-tandem-diabetes-care-inc-technically-bullish-or-bearish-3593701",
        "imagepath": "",
        "date": "2025-10-06 12:05:11",
        "description": "As of 3 October 2025, the technical trend for Tandem Diabetes Care, Inc. has changed from bearish to mildly bearish. The weekly MACD is mildly bullish, but the monthly MACD remains bearish. The Bollinger Bands and moving averages indicate a mildly bearish stance on both weekly and daily time frames. The KST and Dow Theory show bearish and mildly bearish signals, respectively, on the weekly and monthly charts. \n\nIn terms of returns, Tandem has significantly underperformed the S&P 500 over the year with a return of -63.64% compared to the S&P's 17.82%, and over three years, it has returned -70.92% against the S&P's 82.57%. Overall, the current technical stance is mildly bearish...."
      },
      {
        "title": "Is Tandem Diabetes Care, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-tandem-diabetes-care-inc-technically-bullish-or-bearish-3591770",
        "imagepath": "",
        "date": "2025-10-05 11:50:04",
        "description": "As of 3 October 2025, the technical trend for Tandem Diabetes Care, Inc. has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD remains bearish. The Bollinger Bands and moving averages are both showing mildly bearish signals on the weekly and daily time frames. The KST and Dow Theory are bearish and mildly bearish, respectively, on the weekly and monthly charts. \n\nIn terms of performance, the stock has significantly underperformed the S&P 500 over the longer term, with a year-to-date return of -59.16% compared to the S&P 500's 14.18%, and a one-year return of -63.64% versus the S&P 500's 17.82%. Overall, the current technical stance is mildly bearish, with key indicators such as the moving averages and Bollinger Bands contributing to this view...."
      },
      {
        "title": "Is Tandem Diabetes Care, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-tandem-diabetes-care-inc-technically-bullish-or-bearish-3546480",
        "imagepath": "",
        "date": "2025-09-20 19:33:52",
        "description": "As of 8 July 2025, the technical trend for Tandem Diabetes Care, Inc. has changed from mildly bearish to bearish. The current technical stance is bearish with weak strength. The weekly MACD is mildly bullish, but the monthly MACD is bearish, indicating mixed signals. The daily moving averages are bearish, and both the KST and Bollinger Bands are bearish on a weekly and monthly basis. The Dow Theory shows a mildly bullish stance on the weekly timeframe but no trend on the monthly. \n\nIn terms of performance, the stock has significantly underperformed the S&P 500 over the longer term, with a year-to-date return of -63.24% compared to the S&P 500's 12.22%, and a one-year return of -68.95% versus 17.14% for the index...."
      },
      {
        "title": "Is Tandem Diabetes Care, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-tandem-diabetes-care-inc-overvalued-or-undervalued-3543051",
        "imagepath": "",
        "date": "2025-09-20 18:09:18",
        "description": "As of 3 August 2022, Tandem Diabetes Care, Inc. moved from a fair to risky valuation grade, indicating a deterioration in its investment appeal. The company appears to be overvalued, particularly given its negative P/E ratio and poor return metrics, with a Price to Book Value of 8.91 and an EV to Sales ratio of 1.41. Additionally, the latest ROCE and ROE stand at -65.75% and -69.96%, respectively, highlighting significant operational challenges.\n\nIn comparison to its peers, Tandem's valuation is notably weaker, with TransMedics Group, Inc. trading at a fair valuation with a P/E of 50.23, while Integer Holdings Corp. is categorized as very expensive with a P/E of 41.17. The stock has underperformed significantly against the S&P 500, with a year-to-date return of -63.24% compared to the index's 12.22%, reinforcing the notion that the stock is overvalued in its current state...."
      }
    ],
    "total": 15,
    "sid": "1161440",
    "stock_news_url": "https://www.marketsmojo.com/news/tandem-diabetes-care-inc-1161440"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Tandem Diabetes Care Stock Soars 21.98%, Hits Intraday High of $16.70

2025-11-10 17:49:11

Tandem Diabetes Care, Inc. has seen notable stock activity today, contrasting with the modest performance of the S&P 500. While the company has gained significantly over the past week, its year-long performance reveals a substantial decline. The firm continues to face challenges with profitability and has a market capitalization of USD 845 million.

Tandem Diabetes Care Hits Day Low at $13.25 Amid Price Pressure

2025-11-07 16:37:17

Tandem Diabetes Care, Inc. faced notable volatility on November 6, 2025, with a significant stock decline. Over the past week and month, the stock has continued to drop, reflecting a troubling long-term performance. Financial metrics reveal challenges, including low return on equity and high debt levels, indicating ongoing difficulties.

Tandem Diabetes Care Experiences Revision in Stock Evaluation Amid Market Fluctuations

2025-10-07 20:23:09

Tandem Diabetes Care, Inc. has experienced significant stock fluctuations, with a 52-week high of $42.70 and a low of $9.98. Recent evaluations show mixed technical indicators, and the company's performance has lagged behind the S&P 500, reflecting ongoing challenges in the market.

Is Tandem Diabetes Care, Inc. technically bullish or bearish?

2025-10-07 12:15:01

As of 3 October 2025, the technical trend for Tandem Diabetes Care, Inc. has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, but the monthly MACD remains bearish. The daily moving averages are mildly bearish, and both the weekly and monthly Bollinger Bands are also mildly bearish. The KST and Dow Theory show bearish and mildly bearish signals respectively on the weekly and monthly time frames. In terms of performance, the stock has outperformed the S&P 500 over the past week and month, with returns of 27.31% and 19.32% compared to 1.09% and 4.15% for the index. However, the longer-term returns are significantly negative, with a year-to-date return of -58.33% and a one-year return of -64.07%, while the S&P 500 has gained 14.18% and 17.82% respectively. Overall, the current technical stance is mildly bearish....

Tandem Diabetes Care Stock Soars 12.2% to Intraday High of $14.85

2025-10-06 18:07:37

Tandem Diabetes Care, Inc. saw a notable increase in its stock price on October 3, 2025, reflecting strong short-term performance compared to the S&P 500. However, the company faces long-term challenges, including significant declines over the past year and five years, alongside concerns regarding its financial health.

Is Tandem Diabetes Care, Inc. technically bullish or bearish?

2025-10-06 12:05:11

As of 3 October 2025, the technical trend for Tandem Diabetes Care, Inc. has changed from bearish to mildly bearish. The weekly MACD is mildly bullish, but the monthly MACD remains bearish. The Bollinger Bands and moving averages indicate a mildly bearish stance on both weekly and daily time frames. The KST and Dow Theory show bearish and mildly bearish signals, respectively, on the weekly and monthly charts. In terms of returns, Tandem has significantly underperformed the S&P 500 over the year with a return of -63.64% compared to the S&P's 17.82%, and over three years, it has returned -70.92% against the S&P's 82.57%. Overall, the current technical stance is mildly bearish....

Is Tandem Diabetes Care, Inc. technically bullish or bearish?

2025-10-05 11:50:04

As of 3 October 2025, the technical trend for Tandem Diabetes Care, Inc. has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD remains bearish. The Bollinger Bands and moving averages are both showing mildly bearish signals on the weekly and daily time frames. The KST and Dow Theory are bearish and mildly bearish, respectively, on the weekly and monthly charts. In terms of performance, the stock has significantly underperformed the S&P 500 over the longer term, with a year-to-date return of -59.16% compared to the S&P 500's 14.18%, and a one-year return of -63.64% versus the S&P 500's 17.82%. Overall, the current technical stance is mildly bearish, with key indicators such as the moving averages and Bollinger Bands contributing to this view....

Is Tandem Diabetes Care, Inc. technically bullish or bearish?

2025-09-20 19:33:52

As of 8 July 2025, the technical trend for Tandem Diabetes Care, Inc. has changed from mildly bearish to bearish. The current technical stance is bearish with weak strength. The weekly MACD is mildly bullish, but the monthly MACD is bearish, indicating mixed signals. The daily moving averages are bearish, and both the KST and Bollinger Bands are bearish on a weekly and monthly basis. The Dow Theory shows a mildly bullish stance on the weekly timeframe but no trend on the monthly. In terms of performance, the stock has significantly underperformed the S&P 500 over the longer term, with a year-to-date return of -63.24% compared to the S&P 500's 12.22%, and a one-year return of -68.95% versus 17.14% for the index....

Is Tandem Diabetes Care, Inc. overvalued or undervalued?

2025-09-20 18:09:18

As of 3 August 2022, Tandem Diabetes Care, Inc. moved from a fair to risky valuation grade, indicating a deterioration in its investment appeal. The company appears to be overvalued, particularly given its negative P/E ratio and poor return metrics, with a Price to Book Value of 8.91 and an EV to Sales ratio of 1.41. Additionally, the latest ROCE and ROE stand at -65.75% and -69.96%, respectively, highlighting significant operational challenges. In comparison to its peers, Tandem's valuation is notably weaker, with TransMedics Group, Inc. trading at a fair valuation with a P/E of 50.23, while Integer Holdings Corp. is categorized as very expensive with a P/E of 41.17. The stock has underperformed significantly against the S&P 500, with a year-to-date return of -63.24% compared to the index's 12.22%, reinforcing the notion that the stock is overvalued in its current state....

View All News